ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has announced the addition of a portfolio of new cardiovascular stents and related products, which have already been CE-marked for commercialization in several multibillion dollar markets, including Europe, Asia and India.
